Account
BTVi finds ad sales partner in Helios Media
MUMBAI: Business Broadcast Network Private Limited (BBNPL) announced the launch of their new channel BTVi from 1st August 2016, and has aligned with Helios Media to manage the ad-sales revenue monetisation for the channel.
Keeping in mind the need to have a content oriented sales approach, BBNPL has partnered with Helios Media which is a specialized sales company.
Speaking on the association BTVi COO Monica Tata said, “In an environment such as Business News, it is extremely important that the team fronting the ad-sales understands the pulse of the content, at the same time, provides tailored creative brand solutions and cross-platform opportunities to inform and engage with the core audience. In Helios Media, we found the team to be very proficient in their capability in delivering the mandate.”
Helios Media MD Divya Radhakrishnan said “We have always taken up channels with a unique proposition in the market and helped brands to participate in the content with an objective to provide the appropriate ambience for brands to communicate with their audiences. In BTVi, we are very positive for being able deliver in the financial ecosystem a right fitment.”
Helios Media CSO Shrutish Maharaj said “We wish to approach the market with inclusive programming and solution based selling and have put together a dynamic team who share our passion for the subject.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
